A Study of Irinotecan Liposome in Advanced Pancreatic Cancer

Clinical trial NCT04796948 · COMPLETED

Trial details

NCT number: NCT04796948
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer

Start date: 2021-04-08
Primary completion: 2024-06-28
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.